Dr. Tehila Ben Moshe is the Co-Founder, CEO and Chairwoman of Biond Biologics, an innovative biotech company founded in 2016 and aims to discover and develop breakthrough therapies for the treatment of cancer.

Biond Biologics focus on developing innovative biological drugs for novel oncology targets by uncovering immunoregulatory pathways and by enabling the intracellular delivery of biologics. The company’s vision is to bring its innovative drugs to patients based on synergistic long-term collaborations with leading global companies.